Tags

Type your tag names separated by a space and hit enter

Anaesthetic management of caesarean section in a patient with myelodysplastic syndrome.
Can J Anaesth. 1998 Feb; 45(2):157-63.CJ

Abstract

PURPOSE

This case report describes the anaesthetic management for Caesarean section in a patient with myelodysplastic syndrome.

CLINICAL FEATURES

A woman with myelodysplastic syndrome underwent Caesarean section on two occasions. The first Caesarean section was performed at age 20 yr using general anaesthesia with nitrous oxide-oxygen and fentanyl. In her second pregnancy at 25 yr, there was severe pancytopenia at 28-wk gestation with a leukocyte count 3.6 x 10(9).L-1, erythrocyte count 1.2 x 10(12).L-1, haemoglobin 50 g.L-1, haematocrit 14.7% and platelet count 51 x 10(9).L-1. Following leukocyte poor red cells and platelet transfusion, general anaesthesia was maintained with nitrous oxide-oxygen-sevoflurane and fentanyl. Both operations were uneventful and healthy infants were delivered.

CONCLUSION

It is important to have a team approach (anaesthetist, obstetrician and haematologist) for the perianaesthetic management of patients with myelodysplastic syndrome. An exact assessment of the haematological condition, the need for prophylactic treatment and anaesthetic management should be determined for each individual patient.

Authors+Show Affiliations

Department of Anesthesiology, Shimane Medical University, Izumo City, Japan.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

9512852

Citation

Hara, K, et al. "Anaesthetic Management of Caesarean Section in a Patient With Myelodysplastic Syndrome." Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie, vol. 45, no. 2, 1998, pp. 157-63.
Hara K, Saito Y, Morimoto N, et al. Anaesthetic management of caesarean section in a patient with myelodysplastic syndrome. Can J Anaesth. 1998;45(2):157-63.
Hara, K., Saito, Y., Morimoto, N., Sakura, S., & Kosaka, Y. (1998). Anaesthetic management of caesarean section in a patient with myelodysplastic syndrome. Canadian Journal of Anaesthesia = Journal Canadien D'anesthesie, 45(2), 157-63.
Hara K, et al. Anaesthetic Management of Caesarean Section in a Patient With Myelodysplastic Syndrome. Can J Anaesth. 1998;45(2):157-63. PubMed PMID: 9512852.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Anaesthetic management of caesarean section in a patient with myelodysplastic syndrome. AU - Hara,K, AU - Saito,Y, AU - Morimoto,N, AU - Sakura,S, AU - Kosaka,Y, PY - 1998/3/26/pubmed PY - 1998/3/26/medline PY - 1998/3/26/entrez SP - 157 EP - 63 JF - Canadian journal of anaesthesia = Journal canadien d'anesthesie JO - Can J Anaesth VL - 45 IS - 2 N2 - PURPOSE: This case report describes the anaesthetic management for Caesarean section in a patient with myelodysplastic syndrome. CLINICAL FEATURES: A woman with myelodysplastic syndrome underwent Caesarean section on two occasions. The first Caesarean section was performed at age 20 yr using general anaesthesia with nitrous oxide-oxygen and fentanyl. In her second pregnancy at 25 yr, there was severe pancytopenia at 28-wk gestation with a leukocyte count 3.6 x 10(9).L-1, erythrocyte count 1.2 x 10(12).L-1, haemoglobin 50 g.L-1, haematocrit 14.7% and platelet count 51 x 10(9).L-1. Following leukocyte poor red cells and platelet transfusion, general anaesthesia was maintained with nitrous oxide-oxygen-sevoflurane and fentanyl. Both operations were uneventful and healthy infants were delivered. CONCLUSION: It is important to have a team approach (anaesthetist, obstetrician and haematologist) for the perianaesthetic management of patients with myelodysplastic syndrome. An exact assessment of the haematological condition, the need for prophylactic treatment and anaesthetic management should be determined for each individual patient. SN - 0832-610X UR - https://www.unboundmedicine.com/medline/citation/9512852/Anaesthetic_management_of_caesarean_section_in_a_patient_with_myelodysplastic_syndrome_ L2 - https://doi.org/10.1007/BF03013256 DB - PRIME DP - Unbound Medicine ER -